Adcytherix Raises EUR 105M Series A to Accelerate

Adcytherix Raises EUR 105M Series A to Accelerate

Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led by Bpifrance with...
THEON strengthens transatlantic defense cooperation at AUSA

THEON strengthens transatlantic defense cooperation at AUSA

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) Washington, D.C. - October 16, 2025.  THEON, a global market leader in night...
Entera Bio to Present New Clinical Data from Phase 2 Trial

Entera Bio to Present New Clinical Data from Phase 2 Trial

JERUSALEM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein...
EyePoint Announces Proposed Public Offering of Common

EyePoint Announces Proposed Public Offering of Common

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics...
Collegium to Celebrate 10-Year Anniversary with Nasdaq

Collegium to Celebrate 10-Year Anniversary with Nasdaq

STOUGHTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management team will ring the...
Salarius Pharmaceuticals Regains Compliance with All Nasdaq

Salarius Pharmaceuticals Regains Compliance with All Nasdaq

HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on October 10, 2025...
THEON strengthens transatlantic defense cooperation at AUSA

THEON plans to acquire 9.8% stake in Exosens

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 11 October 2025 – Theon International Plc (THEON) has entered into a definitive...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq

CAMBRIDGE, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules...
Aptera Motors Approved for Nasdaq Listing, Set to Trade

Aptera Motors Approved for Nasdaq Listing, Set to Trade

CARLSBAD, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (“Aptera” or the “Company”), the solar mobility company focused on developing...
Hadrian Capital Partners Inc. Provides Update on its

Hadrian Capital Partners Inc. Provides Update on its

VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Hadrian Capital Partners Inc. announced today that it and its affiliate Hadrian Capital...
Talen Energy Announces Launch of Proposed Senior Notes

Talen Energy Announces Launch of Proposed Senior Notes

HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Talen Energy Corporation (“TEC,” “we” or “our”) (NASDAQ: TLN) announced today that Talen Energy Supply,...
DeFi Development Corp. (DFDV) Announces Launch of Weekly

DeFi Development Corp. (DFDV) Announces Launch of Weekly

BOCA RATON, FL, Oct. 09, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DFDV” or the “Company”), the first U.S. public...